CNSX:BUZZ

VanEck Social Sentiment ETF (BUZZ) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BUZZ stock logo

About VanEck Social Sentiment ETF Stock (CNSX:BUZZ)

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates in the psychedelic smartshop market. In addition, the company engages in the adult use psychedelic retail business; and researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of Cepharanthine. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.

BUZZ Stock News Headlines

The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
VanEck Fined $1.75M Over Dave Portnoy's ETF Role
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
BUZZ VanEck Vectors Social Sentiment ETF
See More Headlines
Receive BUZZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Social Sentiment ETF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Daniel Cohen
    Chairman & CEO
  • Mr. Keith Li (Age 40)
    Chief Financial Officer
    Comp: $91k
  • Dr. Paul Van Slyke
    Chief Scientific Officer
  • Harry Resin
    Pres of Super Smart

BUZZ Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of VanEck Social Sentiment ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Social Sentiment ETF investors own include Aphria (APHA), Annovis Bio (ANVS), Amex Exploration (AMX), Amyris (AMRS), Aleafia Health (ALEAF), Aldeyra Therapeutics (ALDX), Agraflora Organics International (AGRA) and Acreage (ACRGF).

How do I buy shares of VanEck Social Sentiment ETF?

Shares of BUZZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (CNSX:BUZZ) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners